Buy HDFC Bank Ltd For Target Rs.1,147 By Elara Capital
On expected lines, valuation reassuring
HDFC Bank (HDFCB IN) Q3FY26 PAT of INR 186bn , up 11% YoY , was ahead of our estimates on
higher treasury income even as core PPoP (ex -treasury) was in line with our estimates ;
characteristically Q3FY26 had steady undertones , underlying steady progress. Q3FY26 saw
steady loan growth outcomes , up 12% YoY & 2.7% QoQ , with the bank confident of tracking
above system growth in FY27. Q3 NIM surprised , up 8bp QoQ, feeding into 3.4% QoQ NII
growth (better than our expectation s). Better liquidity scenario and changes in regulatory
approach played in favor of HDFC B, making balance sheet realignment easier. We have been
arguing about its conundrum to manage growth vs NIM vs LCR vs CD ratio outcomes, which
are likely to cause dislocation . T ransition ing through the tough part journey here after should
be more amicable for the bank, but transition on LDR would be a challenge . As the bank has
underperformed the broader index by 7% in the p ast month it trades at 1.9x FY28 E P/BV
rendering the risk -reward favorable. We revise to Buy with an unchanged TP of INR 1,147.
Traversed through tougher transition, but monitorable persists: FY25 saw slower loan
growth outcomes, with the bank seeing sub -6% YoY loan growth in its bid to accelerate CD
ratio outcome . However , Q3FY26 saw trend reversal with 12% YoY loan growth. Deposit
growth was lower , up 11.6% YoY , with the ratio going up again . While bank directionally
maintained guidance for lower CD ratio , we see it stretched and expect a more calibrated
approach to CD ratio outcomes here after, which would pave the way for steady
normalization. HDFCB retained its stance of higher -than -industry growth in FY27, which
seems plausible as momentum in the machinery (bank’s infrastructure) takes over.
Much to ponder on with focus on NIM trajectory: HDFCB reported an 8bp QoQ rise in NIM (to
3.35% on total assets). Better liquidity, CRR cut impact and rising CD ratio benefitted NIM .
Deposits needs in FY27 may call for stickier costs , feeding into challenges as the bank tries
to balance between LCR vs LDR vs growth vs NIM outcomes. Given already low credit cost,
levers in opex would sustain earnings pressure in the near term . Q3 had one -off opex ( Labour
Law change impact) of INR 8bn (much higher than reported by peers) ,setting the base higher.
Asset quality remains key differentiator: Slippages were curtailed (1.2% vs 1.1% QoQ), with
rise in the agri segment (seasonal trend) while steady progress was seen in other segments.
The bank seems confident of no major red flags. The bank carries total (floating and
contingent) buffer of 1.3% of loans, which render s comfort. We see steady credit cost for the
bank.
Revise to Buy with an unchanged TP of INR 1,147: A merger of this scale is an onerous ask,
but HDFCB is doing a commendable job , in our view . The p ast two years ha ve been
challenging , undergoing transition on both sides of balance sheets. We see near -term
challenges easing . We believe valuation re -rating could take time, but we are closer to the
steady normalization phase. Having corrected by 7% in the past month, we view the risk -
reward as favo rable ; thus , we revise to Buy from Accumulate with a n unchanged TP of INR
1,147based on a SOTP method .
Please refer disclaimer at Report
SEBI Registration number is INH000000933
